For soluble PD-1 and PD-L1 (B7-H1), microtiter plates were coated overnight at 4°C with 1 µg/ml of anti-human PD-1 antibody (AF1086, R&D Systems, UK) or anti-human B7-H1 antibody (AF156, R&D Systems). After blocking, serum samples were diluted 1∶4 for sPD-1 and 1∶2 for sPD-L1 molecule detection and purified recombinant human PD-17Fc (1086-PD, R&D Systems) and B7-H17Fc (156-B7, R&D Systems) chimeras were used as standards. Further, plates were incubated with 1 µg/ml of anti-human PD-1 monoclonal antibody (mAb, MAB1086, R&D Systems) or B7-H1 mAb (MAB156, R&D Systems), washed and a solution of conjugated goat anti-mouse IgG was added. Color reactions were developed using the TMB peroxidase substrate system (Sigma-Aldrich, St. Louis, MO) and measured at 450 nm. All samples were analyzed in duplicate and standard curves were run in each plate. No cross-reactivity between PD-1 and PD-L1 molecules was observed and intra- and inter-assay variability was evaluated to be <9% in all cases.
Af1086
AF1086 is a high-quality lab equipment product designed for use in research and scientific applications. It is a specialized tool that serves a core function, but its intended use should not be extrapolated beyond the factual information provided.
Lab products found in correlation
8 protocols using af1086
Quantification of Soluble Immune Checkpoint Molecules
For soluble PD-1 and PD-L1 (B7-H1), microtiter plates were coated overnight at 4°C with 1 µg/ml of anti-human PD-1 antibody (AF1086, R&D Systems, UK) or anti-human B7-H1 antibody (AF156, R&D Systems). After blocking, serum samples were diluted 1∶4 for sPD-1 and 1∶2 for sPD-L1 molecule detection and purified recombinant human PD-17Fc (1086-PD, R&D Systems) and B7-H17Fc (156-B7, R&D Systems) chimeras were used as standards. Further, plates were incubated with 1 µg/ml of anti-human PD-1 monoclonal antibody (mAb, MAB1086, R&D Systems) or B7-H1 mAb (MAB156, R&D Systems), washed and a solution of conjugated goat anti-mouse IgG was added. Color reactions were developed using the TMB peroxidase substrate system (Sigma-Aldrich, St. Louis, MO) and measured at 450 nm. All samples were analyzed in duplicate and standard curves were run in each plate. No cross-reactivity between PD-1 and PD-L1 molecules was observed and intra- and inter-assay variability was evaluated to be <9% in all cases.
Quantitative Antibody Binding ELISA
Quantitative Antibody Binding ELISA
anti-human IgG (SouthernBiotech, 2040-01) using Certified Reference Material 470
(ERMs-DA470, Sigma-Aldrich) as a standard. To test specific binding of antibody
constructs, ELISA plates were coated with 2 μg ml−1 of type I
recombinant human collagen (Millipore, CC050), 2 μg ml−1 of an
anti-human LAIR1 antibody (clone DX26, BD Biosciences 550810), 1 μg
ml−1 of recombinant human GM-CSF (Gentaur), 2 μg
ml−1 of an anti-PD1 or an anti-SLAM antibody (R&D Systems,
AF1086 and AF164). Plates were blocked with 1% bovine serum albumin (BSA) and incubated
with titrated antibodies, followed by AP-conjugated goat anti-human IgG, Fcγ
fragment specific (Jackson Immuno Research, 109-056-098). Plates were then washed,
substrate (p-NPP, Sigma) was added and plates were read at 405 nm.
Immunohistochemical Identification of Tfh Cells
Immunoblotting Analysis of Protein Expression
µg total protein/lane was used for each cell lysate. After transferring the
proteins to polyvinylidene difluoride membranes, the membranes were hybridized
with antibodies against PD-1 (AF1086, R & D System), RANTES (CCL5; C-12,
Santa Cruz Biotechnology, Dallas, TX), CD19 (PDR134, Santa Cruz Biotechnology),
AKT1 (B1, Santa Cruz Biotechnology), or β-actin (C4, Santa Cruz Biotechnology).
Quantification of the proteins bands on X-ray films was done using an ImageJ
software (
Modulation of PBMC Immune Responses
Modulation of Chemotherapy Response by PD-1 Signaling
Multiplex Immunofluorescence Staining of Tissue Sections
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!